Solsona E, Iborra I, Rubio J, Casanova J L, Ricós J V, Calabuig C
Department of Urology, Instituto Valenciano de Oncologia, Valencia, Spain.
J Urol. 2001 May;165(5):1506-9.
We prospectively validated the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative lymph nodes.
In a retrospective study of 66 patients we demonstrated the predictive value of the association of local tumor stage and grade for occult micrometastasis, identifying 3 risk groups. A therapy strategy was designed according to these risk groups. A total of 37 consecutive patients were included in a prospective study in which the same criteria for risk group allocation and the same therapeutic recommendations were used as in the retrospective study.
In the prospective study we noted positive lymph nodes in 11% of stage T1, 63% of stages T2-3, 15% of grade 1, 67% of grade 2 and 75% of grade 3 cases. The incidence of positive nodes was 0% in the low, 83.3% in the high and 33.3% in the intermediate risk group. These rates were similar to those in the retrospective study with no significant difference.
The predictive value of the association of local tumor stage and grade for occult lymph node micrometastasis was validated in a prospective study. This factor allows the differentiation of 3 risk groups of patients with high reliability in the low and high risk groups. However, other prognostic factors are needed in the intermediate risk group to improve the prediction of lymph node involvement.
我们前瞻性地验证了局部肿瘤分期和分级作为阴茎癌且临床淋巴结阴性患者隐匿性淋巴结微转移预测因素的相关性。
在一项对66例患者的回顾性研究中,我们证明了局部肿瘤分期和分级联合对于隐匿性微转移的预测价值,确定了3个风险组。根据这些风险组设计了一种治疗策略。共有37例连续患者纳入一项前瞻性研究,其中风险组分配标准和治疗建议与回顾性研究相同。
在前瞻性研究中,我们发现T1期患者中有11%出现阳性淋巴结,T2 - 3期患者中有63%,1级患者中有15%,2级患者中有67%,3级患者中有75%。低风险组阳性淋巴结发生率为0%,高风险组为83.3%,中风险组为33.3%。这些比率与回顾性研究中的相似,无显著差异。
在前瞻性研究中验证了局部肿瘤分期和分级联合对于隐匿性淋巴结微转移的预测价值。该因素能够在低风险组和高风险组中高度可靠地区分出3个风险组的患者。然而,中风险组需要其他预后因素来改善对淋巴结受累情况的预测。